Supplemental material
OncoImmunology
Volume 12, 2023 - Issue 1
Open access
1,409
Views
1
CrossRef citations to date
0
Altmetric
Original Research
T-cell dysfunction in natural killer/T-cell lymphoma
Xiaoyan Fenga Department of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China;b Academy of Medical Sciences of Zhengzhou University, Zhengzhou, Henan, China;c Lymphoma Diagnosis and Treatment Centre of Henan Province, Zhengzhou, Henan, ChinaView further author information
, Miaomiao Menga Department of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China;b Academy of Medical Sciences of Zhengzhou University, Zhengzhou, Henan, China;c Lymphoma Diagnosis and Treatment Centre of Henan Province, Zhengzhou, Henan, ChinaView further author information
, Hongwen Lia Department of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China;c Lymphoma Diagnosis and Treatment Centre of Henan Province, Zhengzhou, Henan, ChinaView further author information
, Yuyang Gaoa Department of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China;c Lymphoma Diagnosis and Treatment Centre of Henan Province, Zhengzhou, Henan, ChinaView further author information
, Wenting Songa Department of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China;b Academy of Medical Sciences of Zhengzhou University, Zhengzhou, Henan, China;c Lymphoma Diagnosis and Treatment Centre of Henan Province, Zhengzhou, Henan, ChinaView further author information
, Ruiqing Dia Department of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China;d Nursing Department, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, ChinaView further author information
, Zhaoming Lia Department of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China;c Lymphoma Diagnosis and Treatment Centre of Henan Province, Zhengzhou, Henan, ChinaView further author information
, Xudong Zhanga Department of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China;c Lymphoma Diagnosis and Treatment Centre of Henan Province, Zhengzhou, Henan, ChinaView further author information
& Mingzhi Zhanga Department of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China;c Lymphoma Diagnosis and Treatment Centre of Henan Province, Zhengzhou, Henan, ChinaCorrespondence[email protected]
View further author information
show allView further author information
Article: 2212532
|
Received 20 Dec 2022, Accepted 08 May 2023, Published online: 24 May 2023
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.